Caricamento...

P38 MAPK contributes to resistance and invasiveness of HER2-overexpressing breast cancer

Intrinsic or acquired resistance to the HER2-targeted therapy trastuzumab is a clinical concern in the treatment of patients with HER2-over-expressing metastatic breast cancers. We demonstrate here that multiple models of intrinsic and acquired resistance exhibit increased phosphorylation of p38 MAP...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Med Chem
Autori principali: Donnelly, Siobhan M., Paplomata, Elisavet, Peake, Bridgette M., Sanabria, Eduardo, Chen, Zhengjia, Nahta, Rita
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4262834/
https://ncbi.nlm.nih.gov/pubmed/24251561
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !